Targeting gut-microbiota for gastric cancer treatment: a systematic review DOI Creative Commons
Amir Marashi,

S. A. Hasany,

Sadra Moghimi

и другие.

Frontiers in Medicine, Год журнала: 2024, Номер 11

Опубликована: Авг. 2, 2024

Preclinical research has identified the mechanisms via which bacteria influence cancer treatment outcomes. Clinical studies have demonstrated potential to modify microbiome in treatment. Herein, we systematically analyze how gut microorganisms interact with chemotherapy and immune checkpoint inhibitors, specifically focusing on affect pharmacokinetics pharmacodynamics of

Язык: Английский

CPNE8 Promotes Gastric Cancer Metastasis by Modulating Focal Adhesion Pathway and Tumor Microenvironment DOI Creative Commons
Peiling Zhang, Xiaofei Cao,

Mingmei Guan

и другие.

International Journal of Biological Sciences, Год журнала: 2022, Номер 18(13), С. 4932 - 4949

Опубликована: Янв. 1, 2022

Little is known about the oncogenic role or biological function of copine Ⅷ (CPNE8) in gastric cancer (GC).Based on TCGA database, we screened for CPNE8 and analyzed expression GC.The correlations between clinical features were using GEO databases.The prognostic value was assessed Cox analysis Kaplan-Meier curves.The results showed that increased positively correlated with metastasis can be considered an independent risk factor poor survival.We found promote cell proliferation, migration, invasiveness GC vitro vivo experiments.Our study demonstrated promotes tumor progression via regulation focal adhesion, these effects rescued by adhesion kinase (FAK) inhibitor GSK2256098 knockdown FAK.In addition, significantly infiltration cancer-associated fibroblasts immune cells, as various algorithms, high predicted efficacy checkpoint therapy.Our findings suggest modulates microenvironment to could serve a novel biomarker GC.

Язык: Английский

Процитировано

26

Healthy Diet, Polygenic Risk Score, and Upper Gastrointestinal Cancer Risk: A Prospective Study from UK Biobank DOI Open Access

Wenmin Liu,

Tianpei Wang,

Meng Zhu

и другие.

Nutrients, Год журнала: 2023, Номер 15(6), С. 1344 - 1344

Опубликована: Март 10, 2023

Dietary and genetic factors are considered to be associated with UGI cancer risk. However, examinations of the effect healthy diet on risk extent which modifies impact susceptibility remains limited. Associations were analyzed through Cox regression UK Biobank data (n = 415,589). Healthy diet, based "healthy score," was determined according fruit, vegetables, grains, fish, meat consumption. We compared adherence cancer. also constructed a polygenic score (UGI-PRS) assess combined diet. For results high reduced 24% (HR high-quality diet: 0.76 (0.62-0.93), p 0.009). A unhealthy observed, HR reaching 1.60 (1.20-2.13, 0.001). Among participants risk, absolute five-year incidence significantly reduced, from 0.16% 0.10%, by having In summary, decreased individuals can attenuate adopting

Язык: Английский

Процитировано

16

Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers DOI
Zaki H. Hakami

Pathology - Research and Practice, Год журнала: 2024, Номер 255, С. 155216 - 155216

Опубликована: Фев. 16, 2024

Язык: Английский

Процитировано

5

Tumor microenvironment characteristics of lipid metabolism reprogramming related to ferroptosis and EndMT influencing prognosis in gastric cancer DOI Creative Commons
Qian Zhao,

Hui Yu,

Mengqi Shi

и другие.

International Immunopharmacology, Год журнала: 2024, Номер 137, С. 112433 - 112433

Опубликована: Июнь 13, 2024

Gastric cancer (GC) is a refractory malignant tumor with high heterogeneity, low rate of early diagnosis, and poor patient prognosis. Lipid metabolism reprogramming plays critical role in tumorigenesis progression, but its prognostic regulatory mechanism GC are rarely studied. Thus, the identification signatures related to lipid necessary may present new avenue for improving overall prognosis GC.

Язык: Английский

Процитировано

5

Targeting gut-microbiota for gastric cancer treatment: a systematic review DOI Creative Commons
Amir Marashi,

S. A. Hasany,

Sadra Moghimi

и другие.

Frontiers in Medicine, Год журнала: 2024, Номер 11

Опубликована: Авг. 2, 2024

Preclinical research has identified the mechanisms via which bacteria influence cancer treatment outcomes. Clinical studies have demonstrated potential to modify microbiome in treatment. Herein, we systematically analyze how gut microorganisms interact with chemotherapy and immune checkpoint inhibitors, specifically focusing on affect pharmacokinetics pharmacodynamics of

Язык: Английский

Процитировано

5